Possible metabolic side effects of beta-adrenergic blocking drugs.
作者信息
Helgeland A, Hjermann I, Leren P, Holme I
出版信息
Br Med J. 1978 Apr 1;1(6116):828. doi: 10.1136/bmj.1.6116.828.
Abstract
摘要
相似文献
1
Possible metabolic side effects of beta-adrenergic blocking drugs.β-肾上腺素能阻断药物可能的代谢副作用。
Br Med J. 1978 Apr 1;1(6116):828. doi: 10.1136/bmj.1.6116.828.
2
The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
J Cardiovasc Pharmacol. 1984;6 Suppl 3:S474-6.
3
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.未经治疗和接受噻嗪类药物治疗的轻度高血压患者的血清甘油三酯和血清尿酸。奥斯陆研究。
Am J Med. 1978 Jan;64(1):34-8. doi: 10.1016/0002-9343(78)90177-8.
4
5
Oslo Hypertension Study.奥斯陆高血压研究
Drugs. 1986;31 Suppl 1:41-5. doi: 10.2165/00003495-198600311-00008.
6
[A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
Acta Med Austriaca. 1984;11(2):49-53.
7
[Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].普萘洛尔与甲基多巴治疗高血压的比较（一项双盲试验）
Ugeskr Laeger. 1973 May 17;135(20):974-6.
8
[Effect of hydrochlorothiazide and methyldopa on lipid metabolism in patients with essential hypertension].
AMB Rev Assoc Med Bras. 1988 Mar-Apr;34(2):41-3.
9
引用本文的文献
1
Sotalol and metoprolol comparison of their anti-hypertensive effect.索他洛尔与美托洛尔抗高血压作用的比较。
Eur J Clin Pharmacol. 1981;21(2):87-92. doi: 10.1007/BF00637506.
2
[Antihypertensive therapy and lipid metabolism].[抗高血压治疗与脂质代谢]
Klin Wochenschr. 1984 Mar 1;62(5):193-202. doi: 10.1007/BF01721044.
3
[The influence of beta-receptor blockers on metabolism (author's transl)].β受体阻滞剂对代谢的影响（作者译）
Klin Wochenschr. 1981 Jan 15;59(2):49-57. doi: 10.1007/BF01477283.
4
Plasma apolipoproteins and lipids in normal persons and patients with hypertension.正常人和高血压患者的血浆载脂蛋白及脂质
Korean J Intern Med. 1986 Jul;1(2):214-21. doi: 10.3904/kjim.1986.1.2.214.
5
The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.抗高血压药物对血脂和脂蛋白的影响。II. 非利尿药物。
Drugs. 1986 Oct;32(4):335-57. doi: 10.2165/00003495-198632040-00003.
6
Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.阿替洛尔和美托洛尔治疗期间对胰岛素的敏感性：高血压患者碳水化合物和脂蛋白代谢影响的随机双盲研究。
BMJ. 1989 Apr 29;298(6681):1152-7. doi: 10.1136/bmj.298.6681.1152.
7
Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.β-肾上腺素能受体阻滞剂与糖尿病患者的血糖控制
Br Med J. 1979 Jan 20;1(6157):159-61. doi: 10.1136/bmj.1.6157.159.
8
High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.高密度脂蛋白胆固醇与抗高血压药物：奥斯陆研究
Br Med J. 1978 Aug 5;2(6134):403. doi: 10.1136/bmj.2.6134.403.
9
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.阿替洛尔：对其药理特性以及在心绞痛和高血压治疗中的疗效的综述。
Drugs. 1979 Jun;17(6):425-60. doi: 10.2165/00003495-197917060-00001.
本文引用的文献
1
[Saluretics or beta blocking agents in the treatment of hypertension?].
Lakartidningen. 1976 May 5;73(19):1824-6.
2
Elevation of serum lipid levels during diuretic therapy of hypertension.高血压利尿治疗期间血清脂质水平的升高。
Am J Med. 1976 Nov;61(5):748-57. doi: 10.1016/0002-9343(76)90156-x.
3
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.未经治疗和接受噻嗪类药物治疗的轻度高血压患者的血清甘油三酯和血清尿酸。奥斯陆研究。
Am J Med. 1978 Jan;64(1):34-8. doi: 10.1016/0002-9343(78)90177-8.
4
Metabolic effects of beta-adrenoreceptor blockers.β-肾上腺素能受体阻滞剂的代谢效应
Drugs. 1976;11 SUPPL 1:121-6. doi: 10.2165/00003495-197600111-00027.
Zotero 插件